Solano Overview
- Founded
-
2013
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Solano General Information
Description
Owner and operator of a biopharmaceutical company. The company develops a class of mitochondrial-targeted antioxidants for the treatment of neurodegenerative diseases.
Contact Information
Website
www.solanopharma.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
- 820 Heinz Avenue
- Berkeley, CA 94710
- United States
Solano Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Jul-2019 | Completed | Out of Business | |||
| 2. Grant | 15-Jun-2014 | 00000 | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
Solano Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Janet Leeds | Chief Executive Officer | ||
| Cynthia McMurray | Co-Founder | ||
| Peter Wipf | Co-Founder |